Pharmaguida

Pharmaguida is an Italian pharmaceutical company founded in 2004 by Nicola Guida, specializing in the development and commercialization of nutraceuticals, medical devices, and food supplements. Headquartered in Pollica, Salerno, the company focuses on therapeutic areas such as pediatrics, gynecology, gastroenterology, and immunology. Pharmaguida is particularly recognized for its research into Lactoferrin, marketed under the Mosiac and Xflor brands, and its long-standing Bimbovit pediatric multivitamin range. The company emphasizes scientific evidence and clinical documentation, maintaining a strong presence at medical congresses and collaborating with healthcare professionals. While its founder Nicola Guida is also known for his 2023 acquisition of the Ternana Calcio football club, Pharmaguida remains a dedicated player in the Italian specialty pharma and wellness sector.